Current stock page

Catalysts

XENE Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

XENEXenon Pharmaceuticals Inc.

Healthcare / Biotechnology

Relative Leader / Watch

Strong Relative Position

BearishEdge 8/10
$40.48−$0.52 (−1.26%)

Latest quote

  • Momentum
    33
  • Value
    —
  • Quality
    68
  • Risk resilience
    49
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Feb 25, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 49/100

Momentum 33/100 and sentiment — before the next covered event.

Recent coverage
2 articles

Updated Nov 15, 2026 · Sentiment 35.42%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 33/100AIQ Edge 8/10 Strong Relative Position
Beat rate
63%
5 of 8 reported periods
Average surprise
+1.2%
Across covered historical reports
Latest result
+1.8%
Nov 9, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 9, 2026—-$1.13-$1.11+1.8%$500K—
Aug 6, 2026—-$1.14-$1.11+2.6%$1.67M—
May 7, 2026—-$1.17-$1.17+0.0%$1.36M—
Feb 26, 2026—-$1.20-$1.31-9.2%-$178.57K—
Nov 3, 2025—-$1.16-$1.15+0.9%——
Aug 11, 2025—-$1.03-$1.07-3.9%——
May 12, 2025—-$0.94-$0.83+11.7%$1.91M$7.5M
Feb 27, 2025—-$0.89-$0.84+5.6%$312.5K—

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
17
Buy
1
Hold
12-month analyst target
$67.86
+67.63% versus current price
Based on 18 analyst observations. Targets are estimates, not predictions.
Low target
$46.00
+13.64% vs latest price
Average target
$67.86
+67.63% vs latest price
High target
$90.00
+122.33% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateFeb 25, 2027

Next known earnings or reporting date.

EPS estimate-$1.14

Current analyst expectation for the upcoming report.

Revenue estimate$1.58M

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score33

Where event reaction would show up first.

AIQ score49/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
18
Average target
$67.86
Target upside
67.63%
Target range
$46.00 - $90.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
2
Neutral
0
Negative
0
gurufocus.com · Nov 9, 2026

Xenon Pharmaceuticals (XENE) Prepares Q3 Earnings Release Amid Mixed Analyst Sentiment

On November 08, 2026, Xenon Pharmaceuticals Inc (NASDAQ: XENE) is set to report its third-quarter earnings after market close on November 9th. The biotech compa

gurufocus.com · Oct 6, 2026

XENE Assumed by Guggenheim -- Buy Rating Assigned with Price Target of $73

Xenon Pharmaceuticals Receives Buy Rating from Guggenheim On October 18, 2023, Guggenheim has initiated coverage on Xenon Pharmaceuticals (XENE) with a Buy r

Open full news and sentiment

XENE Catalysts FAQ

What are the next catalysts for XENE stock?

XENE's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move XENE stock?

Upcoming events that could move XENE include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could XENE's next earnings report affect the stock?

XENE's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive XENE stock higher?

XENE could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt XENE stock?

XENE could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.